Associate Professor, UC Davis Department of Internal Medicine; Co-Founder, Accelerated Medical Diagnostics Inc.
Paul Henderson is an associate professor at the UC Davis Department of Internal Medicine and a co-founder of Accelerated Medical Diagnostics Inc. Henderson received his BS in chemistry from the University of Florida in 1992, a PhD in organic chemistry from Georgia Tech in 1999, and was an NIH Postdoctoral Fellow at MIT from 1999-2002 in the Division of Biological Engineering. His postgraduate work focused on the chemistry of DNA damage, which led him to work at Lawrence Livermore National Laboratory (LLNL) as a biomedical scientist for five years prior to his current positions.
Henderson’s research focuses on the relationship between drug-DNA interactions and response of cancer patients to chemotherapy. Preclinical success with the platinum-based treatment of lung and bladder cancer cells motivated the founding of Accelerated Medical Diagnostics, which is sponsoring an ongoing clinical trial at UC Davis, UCSF and UCLA with plans for study expansion and commercialization in the European Union.
The goal of the company is to develop and commercialize a test to predict which cancer patients will respond to chemotherapy.